Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important pathogens affecting the global swine industry. Vaccination is still a main strategy for PRRSV control; however, host factors associated with vaccine efficacy remain poorly understood. Growing evidence suggests that mucosa-associated microbiomes may play a role in the responses to vaccination. In this study, we investigated the effects of a killed virus vaccine on the gut microbiome diversity in pigs. Fecal microbial communities were longitudinally assessed in three groups of pigs (vaccinated/challenged with PRRSV, unvaccinated/challenged with PRRSV, and unvaccinated/unchallenged) before and after vaccination and after viral challenge. We observed significant interaction effects between viral challenge and vaccination on both taxonomic richness and community diversity of the gut microbiota. While some specific taxonomic alterations appear to be enhanced in vaccinated/challenged pigs, others appeared to be more consistent with the levels in control animals (unvaccinated/unchallenged), indicating that vaccination incompletely protects against viral impacts on the microbiome. The abundances of several microbial taxa were further determined to be correlated with the level of viral load and the amount of PRRSV reactive CD4+ and CD8+ T-cells. This study highlights the potential roles of gut microbiota in the response of pigs to vaccination, which may pave the road for the development of novel strategies to enhance vaccine efficacy.
Pulmonary pathogenic fungi cause severe to fatal disseminated infections, especially in immunocompromised patients. Alveolar macrophages form an essential early innate cellular barrier implicated in immunity to pulmonary mycoses. The complex interactions of alveolar macrophages with pathogenic fungi lead to either effective clearance or disease progression. After sensing fungi through pattern-recognizing receptors, alveolar macrophage activation enhances phagocytic and non-phagocytic killing, secretion of cytokines/chemokines, and activation of other immune cells, including adaptive immune cells and neutrophils. Such an orchestrated response involves transcriptomic and metabolic adaptations by macrophages and epigenomic imprinting. Despite their high plasticity with the inflammatory cues, recent studies have shed light on their longevity and functional stability. Nevertheless, some pathogenic fungi have evolved strategies to evade or subvert alveolar macrophage function, leading to persistent and disseminated infections. Understanding the mechanisms of the macrophage-fungal interface helps develop a new line of immune therapeutics and mitigates the challenges of limited arsenals of antifungals.
Non-Tuberculous Mycobacteria (NTM) are ubiquitous in nature, present in soil and water, and cause primary leading to disseminated infections in immunocompromised individuals. NTM infections are surging in recent years due to an increase in an immune-suppressed population, medical interventions, and patients with underlying lung diseases. Host regulators of innate immune responses, frontiers for controlling infections and dissemination, are poorly defined during NTM infections. Here, we describe the role of CBLB, an E3-ubiquitin ligase, for innate immune responses and disease progression in a mouse model of NTM infection under compromised T-cell immunity. We found that CBLB thwarted NTM growth and dissemination in a time- and infection route- dependent manner. Mechanistically, we uncovered defects in many innate immune cells in the absence of Cblb , including poor responses of NK cells, inflammatory monocytes, and conventional dendritic cells. Strikingly, Cblb-deficient macrophages were competent to control NTM growth in vitro . Histopathology suggested the lack of early formation of granulomatous inflammation in the absence of CBLB. Collectively, CBLB is essential to mount productive innate immune responses and help prevent the dissemination during an NTM infection under T-cell deficiency.